首页 | 本学科首页   官方微博 | 高级检索  
     


Tartrate inhibition of prostatic acid phosphatase improves seminal fluid metabolite stability
Authors:Matthew J. Roberts  author-information"  >,Clement W. K. Chow,Martin Lavin  author-information"  >,Gregory K. Pierens  author-information"  >,Robert A. Gardiner
Affiliation:1.Centre for Advanced Imaging,The University of Queensland,Brisbane,Australia;2.Centre for Clinical Research,The University of Queensland,Brisbane,Australia;3.Department of Urology,Royal Brisbane and Women’s Hospital,Brisbane,Australia;4.The University of Queensland,School of Medicine,Brisbane,Australia;5.Edith Cowan University,Joondalup,Australia
Abstract:

Introduction

Human seminal fluid (hSF) has been suggested as a biofluid suitable to characterise male reproductive organ pathology with metabolomics. However, various enzymatic processes, including phosphorylcholine hydrolysis mediated by prostatic acid phosphatase (PAP), cause unwanted metabolite variation that may complicate metabolomic analysis of fresh hSF samples.

Objectives

To investigate the effects of PAP inhibition with tartrate.

Methods

Using NMR spectroscopy, the kinetics of phosphorylcholine to choline hydrolysis was characterized in hSF samples from three subjects at different temperatures and tartrate concentrations. Principal components analysis was used to characterise the effects of tartrate and temperature on personal differences in metabolite profiles. Potential effects of tartrate on RNA quantification were also determined.

Results

Metabolite profiles and the kinetics of phosphorylcholine degradation are reproducible in independent samples from three ostensibly normal subjects. Increasing concentrations of tartrate and refrigerated sample storage (279 K) resulted in greatly reduced reaction rates as judged by apparent rate constants. Multivariate statistical analysis showed that personal differences in metabolite profiles are not overshadowed by tartrate addition, which stabilises phosphorylcholine and choline concentrations. The tartrate signal also served as an internal concentration standard in the samples, allowing the determination of absolute metabolite concentrations in hSF. Furthermore, the presence of tartrate did not affect RNA expression analysis by qPCR.

Conclusion

Based on these results we recommend as standard protocol for the collection of hSF samples, that 10 mM tartrate are added immediately to samples, followed by sample storage/handling at 277 K until clinical processing within 6 h to remove/inactivate enzymes and isolate metabolite supernatant and other cellular fractions.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号